Neumora Therapeutics Management
Management criteria checks 1/4
Neumora Therapeutics' CEO is Henry Gosebruch, appointed in Jul 2023, has a tenure of less than a year. total yearly compensation is $22.00M, comprised of 1.5% salary and 98.5% bonuses, including company stock and options. directly owns 0.33% of the company’s shares, worth $4.96M. The average tenure of the management team and the board of directors is 1.1 years and 3.4 years respectively.
Key information
Henry Gosebruch
Chief executive officer
US$22.0m
Total compensation
| CEO salary percentage | 1.5% |
| CEO tenure | less than a year |
| CEO ownership | 0.3% |
| Management average tenure | 1.1yrs |
| Board average tenure | 3.4yrs |
Recent management updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$254m |
| Dec 31 2023 | US$22m | US$338k | -US$236m |
Compensation vs Market: Henry's total compensation ($USD22.00M) is above average for companies of similar size in the US market ($USD5.65M).
Compensation vs Earnings: Insufficient data to compare Henry's compensation with company performance.
CEO
Henry Gosebruch (50 yo)
less than a year
Tenure
US$21,999,269
Compensation
Mr. Henry O. Gosebruch serves as President, Chief Executive Officer and Director at Neumora Therapeutics, Inc. since July 2023. He serves as an Independent Director at Acelyrin, Inc. since March 17, 2023....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 4.3yrs | US$8.57m | 4.79% $ 72.3m | |
| President | less than a year | US$22.00m | 0.33% $ 5.0m | |
| Chief Legal Officer | less than a year | US$4.41m | no data | |
| Head of Research & Development | less than a year | US$13.58m | no data | |
| Co-Founder & COO | 1.3yrs | no data | 0.18% $ 2.7m | |
| Co-Founder & Advisor | no data | no data | no data | |
| Chief Financial Officer | 2.9yrs | US$3.82m | 0.15% $ 2.3m | |
| Principal Accounting Officer | no data | no data | 0.0024% $ 36.2k | |
| Chief Technical Operations Officer | less than a year | no data | no data | |
| Chief Scientific Officer | 2.3yrs | no data | no data | |
| Chief Human Resources Officer | 1.7yrs | no data | no data | |
| Chief Data Sciences Advisor | no data | no data | no data |
1.1yrs
Average Tenure
50yo
Average Age
Experienced Management: NMRA's management team is not considered experienced ( 1.1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 4.3yrs | US$8.57m | 4.79% $ 72.3m | |
| President | less than a year | US$22.00m | 0.33% $ 5.0m | |
| Independent Director | 3.4yrs | US$485.53k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.3yrs | US$686.60k | 0.017% $ 260.9k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Technology Advisory Board | no data | no data | no data | |
| Independent Director | 1.7yrs | US$671.20k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Technology Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
3.4yrs
Average Tenure
50yo
Average Age
Experienced Board: NMRA's board of directors are considered experienced (3.4 years average tenure).